Kairos Pharma KAPA Balance Sheet (2023-2025)

NYSE KAPA
$0.30 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.10M0.09M3.22M1.27M0.00M3.03M4.49M
Cash & Current Investments (Quarter) 0.10M0.09M3.22M1.27M0.00M3.03M4.49M
Prepaid Assets (Quarter) 0.01M0.01M0.04M0.06M0.09M0.05M
Current Assets (Quarter) 0.10M4.74M4.17M6.05M4.84M5.39M
Non-Current Assets
Intangibles (Quarter) 0.38M0.26M0.22M0.18M0.14M0.06M
Goodwill & Intangibles (Quarter) 0.38M0.26M0.22M0.18M0.14M0.06M
Long-Term Deferred Tax (Quarter) 0.48M1.38M1.71M1.69M1.09M
Non-Current Assets (Quarter) 0.86M0.26M1.60M1.89M1.83M1.15M
Assets (Quarter) 0.96M5.00M5.77M7.94M6.67M6.54M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 2.40M1.53M0.99M0.81M0.68M0.20M
Notes Payables (Quarter) 0.14M
Payables (Quarter) 2.40M1.67M0.99M0.81M0.68M0.20M
Accumulated Expenses (Quarter) 0.04M
Other Accumulated Expenses (Quarter) 0.00M
Total Current Liabilities (Quarter) 2.40M1.67M0.99M0.81M0.68M0.20M
Non-Current Liabilities
Convertible Debt (Quarter) 0.64M
Other Non-Current Liabilities (Quarter) 0.00M
Total Non-Current Liabilities (Quarter) 3.04M1.67M0.99M
Total Liabilities (Quarter) 3.04M1.67M0.99M7.94M6.67M6.54M
Shareholder's Equity
Common Equity (Quarter) -1.87M-2.08M-2.40M-2.65M3.33M4.78M7.13M6.00M6.34M
Liabilities and Shareholders Equity (Quarter) 0.96M5.00M5.77M7.94M6.67M6.54M
Retained Earnings (Quarter) 4.12M-7.83M13.58M-10.08M17.48M20.58M
Treasury Shares (Quarter) 0.15M0.28M0.28M4.54M3.94M4.28M